185 related articles for article (PubMed ID: 18923447)
21. NFATc2 is an intrinsic regulator of melanoma dedifferentiation.
Perotti V; Baldassari P; Molla A; Vegetti C; Bersani I; Maurichi A; Santinami M; Anichini A; Mortarini R
Oncogene; 2016 Jun; 35(22):2862-72. PubMed ID: 26387540
[TBL] [Abstract][Full Text] [Related]
22. Unexpected High Levels of BRN2/POU3F2 Expression in Human Dermal Melanocytic Nevi.
Chitsazan A; Lambie D; Ferguson B; Handoko HY; Gabrielli B; Walker GJ; Boyle GM
J Invest Dermatol; 2020 Jun; 140(6):1299-1302.e4. PubMed ID: 31881210
[No Abstract] [Full Text] [Related]
23. A POU factor binding site upstream of the Chx10 homeobox gene is required for Chx10 expression in subsets of retinal progenitor cells and bipolar cells.
Rowan S; Cepko CL
Dev Biol; 2005 May; 281(2):240-55. PubMed ID: 15893976
[TBL] [Abstract][Full Text] [Related]
24. The POU domain transcription factor Brn-2: elevated expression in malignant melanoma and regulation of melanocyte-specific gene expression.
Eisen T; Easty DJ; Bennett DC; Goding CR
Oncogene; 1995 Nov; 11(10):2157-64. PubMed ID: 7478537
[TBL] [Abstract][Full Text] [Related]
25. Inverse expression states of the BRN2 and MITF transcription factors in melanoma spheres and tumour xenografts regulate the NOTCH pathway.
Thurber AE; Douglas G; Sturm EC; Zabierowski SE; Smit DJ; Ramakrishnan SN; Hacker E; Leonard JH; Herlyn M; Sturm RA
Oncogene; 2011 Jul; 30(27):3036-48. PubMed ID: 21358674
[TBL] [Abstract][Full Text] [Related]
26. Genome-wide analysis of POU3F2/BRN2 promoter occupancy in human melanoma cells reveals Kitl as a novel regulated target gene.
Kobi D; Steunou AL; Dembélé D; Legras S; Larue L; Nieto L; Davidson I
Pigment Cell Melanoma Res; 2010 Jun; 23(3):404-18. PubMed ID: 20337985
[TBL] [Abstract][Full Text] [Related]
27. [Effect of lentivirus-mediated nestin gene silencing on metastatic potential of human melanoma cell line UACC903 in vitro].
Yang X; Xia T; Yu W; Lu X; Xiang P; He F
Nan Fang Yi Ke Da Xue Xue Bao; 2012 Jan; 32(1):7-13. PubMed ID: 22365995
[TBL] [Abstract][Full Text] [Related]
28. Second intron of mouse nestin gene directs its expression in pluripotent embryonic carcinoma cells through POU factor binding site.
Jin ZG; Liu L; Zhong H; Zhang KJ; Chen YF; Bian W; Cheng LP; Jing NH
Acta Biochim Biophys Sin (Shanghai); 2006 Mar; 38(3):207-12. PubMed ID: 16518546
[TBL] [Abstract][Full Text] [Related]
29. BRN2 is a transcriptional repressor of CDH13 (T-cadherin) in melanoma cells.
Ellmann L; Joshi MB; Resink TJ; Bosserhoff AK; Kuphal S
Lab Invest; 2012 Dec; 92(12):1788-800. PubMed ID: 23069940
[TBL] [Abstract][Full Text] [Related]
30. Sox10 has a broad expression pattern in gliomas and enhances platelet-derived growth factor-B--induced gliomagenesis.
Ferletta M; Uhrbom L; Olofsson T; Pontén F; Westermark B
Mol Cancer Res; 2007 Sep; 5(9):891-7. PubMed ID: 17855658
[TBL] [Abstract][Full Text] [Related]
31. SOX10 expression in superficial spreading and nodular malignant melanomas.
Agnarsdóttir M; Sooman L; Bolander A; Strömberg S; Rexhepaj E; Bergqvist M; Ponten F; Gallagher W; Lennartsson J; Ekman S; Uhlen M; Hedstrand H
Melanoma Res; 2010 Dec; 20(6):468-78. PubMed ID: 20890226
[TBL] [Abstract][Full Text] [Related]
32. Phosphorylation of BRN2 modulates its interaction with the Pax3 promoter to control melanocyte migration and proliferation.
Berlin I; Denat L; Steunou AL; Puig I; Champeval D; Colombo S; Roberts K; Bonvin E; Bourgeois Y; Davidson I; Delmas V; Nieto L; Goding CR; Larue L
Mol Cell Biol; 2012 Apr; 32(7):1237-47. PubMed ID: 22290434
[TBL] [Abstract][Full Text] [Related]
33. Human melanoblasts in culture: expression of BRN2 and synergistic regulation by fibroblast growth factor-2, stem cell factor, and endothelin-3.
Cook AL; Donatien PD; Smith AG; Murphy M; Jones MK; Herlyn M; Bennett DC; Leonard JH; Sturm RA
J Invest Dermatol; 2003 Nov; 121(5):1150-9. PubMed ID: 14708619
[TBL] [Abstract][Full Text] [Related]
34. Melanoblasts in culture as an in vitro system to determine molecular changes in melanoma.
Bosserhoff AK; Ellmann L; Kuphal S
Exp Dermatol; 2011 May; 20(5):435-40. PubMed ID: 21496114
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of the stem cell marker nestin reduces tumor growth and invasion of malignant melanoma.
Akiyama M; Matsuda Y; Ishiwata T; Naito Z; Kawana S
J Invest Dermatol; 2013 May; 133(5):1384-7. PubMed ID: 23389394
[No Abstract] [Full Text] [Related]
36. BRN2, a POUerful driver of melanoma phenotype switching and metastasis.
Fane ME; Chhabra Y; Smith AG; Sturm RA
Pigment Cell Melanoma Res; 2019 Jan; 32(1):9-24. PubMed ID: 29781575
[TBL] [Abstract][Full Text] [Related]
37. Relevance of combinatorial profiles of intermediate filaments and transcription factors for glioma histogenesis.
Colin C; Virard I; Baeza N; Tchoghandjian A; Fernandez C; Bouvier C; Calisti A; Tong S; Durbec P; Figarella-Branger D
Neuropathol Appl Neurobiol; 2007 Aug; 33(4):431-9. PubMed ID: 17442061
[TBL] [Abstract][Full Text] [Related]
38. NFIB Mediates BRN2 Driven Melanoma Cell Migration and Invasion Through Regulation of EZH2 and MITF.
Fane ME; Chhabra Y; Hollingsworth DEJ; Simmons JL; Spoerri L; Oh TG; Chauhan J; Chin T; Harris L; Harvey TJ; Muscat GEO; Goding CR; Sturm RA; Haass NK; Boyle GM; Piper M; Smith AG
EBioMedicine; 2017 Feb; 16():63-75. PubMed ID: 28119061
[TBL] [Abstract][Full Text] [Related]
39. Brn-2 represses microphthalmia-associated transcription factor expression and marks a distinct subpopulation of microphthalmia-associated transcription factor-negative melanoma cells.
Goodall J; Carreira S; Denat L; Kobi D; Davidson I; Nuciforo P; Sturm RA; Larue L; Goding CR
Cancer Res; 2008 Oct; 68(19):7788-94. PubMed ID: 18829533
[TBL] [Abstract][Full Text] [Related]
40. Transcription factor Sox10 regulates oligodendroglial Sox9 levels via microRNAs.
Reiprich S; Cantone M; Weider M; Baroti T; Wittstatt J; Schmitt C; Küspert M; Vera J; Wegner M
Glia; 2017 Jul; 65(7):1089-1102. PubMed ID: 28370559
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]